Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 96Inflammatory Breast Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 8Breast Neoplasms, Male 6Breast Carcinoma In Situ 6Neoplasm Metastasis 4Triple Negative Breast Neoplasms 3Neoplasms 3Locally Advanced Breast Cancer 2HER2-positive Breast Cancer 2Colorectal Neoplasms 2Breast Cancer Patients 2Stress, Psychological 1Postoperative Complications 1Pathologic Complete Response 1Neovascularization, Pathologic 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1Motor Activity 1Margins of Excision 1Inflammation 1Infertility 1High-Risk Cancer 1Head and Neck Neoplasms 1Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer 1Colonic Neoplasms 1Cardiotoxicity 1Carcinoma, Lobular 1Breast Cancer-specific Survival 1Breast Cancer Metastatic 1Breast Cancer Invasive 1

Interventions

pembrolizumab 163Carboplatin 146Paclitaxel 125Cyclophosphamide 94130-nm albumin-bound paclitaxel 66Capecitabine 64Gemcitabine 54Doxorubicin 50Albumin-Bound Paclitaxel 45Taxes 42atezolizumab 41Cisplatin 39sacituzumab govitecan 34Nivolumab 34olaparib 32Epirubicin 32Specimen Handling 28Docetaxel 28eribulin 27Bevacizumab 26durvalumab 25Drug Therapy 25Biopsy 24camrelizumab 23Magnetic Resonance Spectroscopy 22toripalimab 19Radiotherapy 17spartalizumab 16Everolimus 15veliparib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Neoadjuvant Therapy × Breast × Clear all
NCT07217990 2026-02-17

NoCUT-BC

Ohio State University Comprehensive Cancer Center

Phase 1/2 Not yet recruiting
84 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Rutgers, The State University of New Jersey

Phase EARLY_PHASE1 Active not recruiting
34 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01147016 2023-04-27

Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery

Barbara Ann Karmanos Cancer Institute

Phase 2 Terminated
8 enrolled 7 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡